396 related articles for article (PubMed ID: 18156925)
21. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
Ti TK
Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
[TBL] [Abstract][Full Text] [Related]
22. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
23. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
24. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
26. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
27. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
[TBL] [Abstract][Full Text] [Related]
28. Multivariate analysis of clinicopathological factors influencing survival following esophagectomy for cancer.
Mirnezami R; Rohatgi A; Sutcliffe RP; Hamouda A; Chandrakumaran K; Botha A; Mason RC
Int J Surg; 2010; 8(1):58-63. PubMed ID: 19897061
[TBL] [Abstract][Full Text] [Related]
29. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
30. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?
D'Journo XB; Doddoli C; Michelet P; Loundou A; Trousse D; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2005 Apr; 27(4):697-704. PubMed ID: 15784377
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
32. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.
Portale G; Hagen JA; Peters JH; Chan LS; DeMeester SR; Gandamihardja TA; DeMeester TR
J Am Coll Surg; 2006 Apr; 202(4):588-96; discussion 596-8. PubMed ID: 16571425
[TBL] [Abstract][Full Text] [Related]
33. Intramucosal esophageal adenocarcinoma: primum non nocere.
Li Z; Rice TW; Liu X; Goldblum JR; Williams SJ; Rybicki LA; Murthy SC; Mason DP; Raymond DP; Blackstone EH
J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1519-24, 1524.e1-3. PubMed ID: 23158254
[TBL] [Abstract][Full Text] [Related]
34. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
[TBL] [Abstract][Full Text] [Related]
35. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
[TBL] [Abstract][Full Text] [Related]
36. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
38. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
39. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
[TBL] [Abstract][Full Text] [Related]
40. [Postoperative respiratory failure in patients with cancer of esophagus and gastric cardia].
Mao YS; Zhang DC; He J; Zhang RG; Cheng GY; Sun KL; Wang LJ; Yang L
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):753-6. PubMed ID: 16483491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
